NICE Ltd. (NCSYF) director David Kostman reports initial holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
NICE Ltd. director David Kostman filed an initial Form 3 reporting his beneficial ownership. He directly holds 19,146 Ordinary Shares, which include 1,744 RSUs and 7,635 ADRs, each ADR representing one Ordinary Share. He also reports multiple option awards over Ordinary Shares, such as options exercisable for 14,920 shares at an exercise price of $151.63 expiring on April 30, 2026 and options for 10,423 shares at $224.18 expiring on September 10, 2026, along with additional grants extending through 2031. The filing records current holdings and does not show new purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Kostman David
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Options — 14,920 shares (Direct);
Ordinary Shares — 19,146 shares (Direct)
Footnotes (1)
- Includes (i) 1,744 restricted stock units ("RSUs"), which vest in accordance with the terms of the applicable awards. Each RSU represents a contingent right to receive one Ordinary Share; and (ii) 7,635 American Depositary Receipts ("ADR"), each of which represents one Ordinary Share. The stock option is fully vested and currently exercisable. The stock option is vested and exercisable with respect to 2,616 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.
FAQ
What does David Kostman’s Form 3 show for NICE Ltd. (NCSYF)?
The Form 3 shows that director David Kostman has reported his existing beneficial ownership in NICE Ltd., including ordinary shares, restricted stock units, ADRs, and several option grants. It is an initial ownership statement and does not reflect new buy or sell transactions.
What RSUs and ADRs are included in David Kostman’s NICE Ltd. holdings?
His reported holdings include 1,744 restricted stock units, each representing a contingent right to receive one Ordinary Share, and 7,635 American Depositary Receipts, with each ADR representing one Ordinary Share of NICE Ltd., according to the ownership footnote disclosure.
What stock option awards for NICE Ltd. does David Kostman report on Form 3?
He reports several option grants over NICE Ltd. Ordinary Shares, including options for 14,920 shares at $151.63 expiring April 30, 2026 and options for 10,423 shares at $224.18 expiring September 10, 2026, plus additional series with later expiration dates.
Are David Kostman’s NICE Ltd. stock options vested and exercisable?
One option grant is described as fully vested and currently exercisable. Another grant is vested for 2,616 Ordinary Shares and will vest in three substantially equal installments on March 30, 2026, June 30, 2026, and September 30, 2026, per the filing footnotes.
Does David Kostman’s NICE Ltd. Form 3 indicate recent insider buying or selling?
The Form 3 lists existing holdings in shares, RSUs, ADRs and options but shows no explicit purchase or sale transactions. All entries are categorized as holdings, and the transaction summary reports no buy or sell activity in the disclosed data.